Replimune Correlations
REPL Stock | USD 13.26 1.67 11.19% |
The current 90-days correlation between Replimune Group and Eliem Therapeutics is -0.09 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Replimune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Replimune Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Replimune Correlation With Market
Modest diversification
The correlation between Replimune Group and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and DJI in the same portfolio, assuming nothing else is changed.
Replimune |
Moving together with Replimune Stock
0.67 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.61 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
Moving against Replimune Stock
0.65 | NKTX | Nkarta Inc | PairCorr |
0.63 | VALN | Valneva SE ADR | PairCorr |
0.59 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.55 | MTEM | Molecular Templates | PairCorr |
0.55 | AGL | agilon health Buyout Trend | PairCorr |
0.53 | BACK | IMAC Holdings | PairCorr |
0.51 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.51 | IPSC | Century Therapeutics | PairCorr |
0.47 | CYRX | Cryoport | PairCorr |
0.45 | TPST | Tempest Therapeutics | PairCorr |
0.44 | ME | 23Andme Holding | PairCorr |
0.36 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.36 | TCHH | Trustcash Holdings | PairCorr |
0.64 | EC | Ecopetrol SA ADR | PairCorr |
0.54 | KO | Coca Cola Aggressive Push | PairCorr |
0.51 | HYMTF | Hyundai Motor | PairCorr |
0.47 | SHG | Shinhan Financial | PairCorr |
0.47 | TLK | Telkom Indonesia Tbk | PairCorr |
0.47 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
0.41 | VFSWW | VinFast Auto | PairCorr |
0.35 | WF | Woori Financial Group | PairCorr |
Related Correlations Analysis
-0.02 | 0.86 | -0.55 | 0.8 | -0.68 | ELYM | ||
-0.02 | -0.17 | 0.1 | 0.11 | -0.01 | HCWB | ||
0.86 | -0.17 | -0.54 | 0.7 | -0.58 | SCPH | ||
-0.55 | 0.1 | -0.54 | -0.39 | 0.51 | MIST | ||
0.8 | 0.11 | 0.7 | -0.39 | -0.63 | MCRB | ||
-0.68 | -0.01 | -0.58 | 0.51 | -0.63 | LUMO | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Replimune Stock performing well and Replimune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Replimune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ELYM | 3.92 | (0.78) | 0.00 | 0.73 | 0.00 | 6.21 | 34.87 | |||
HCWB | 13.20 | 4.04 | 0.35 | (1.01) | 8.16 | 22.00 | 352.85 | |||
SCPH | 2.64 | (0.84) | 0.00 | (0.35) | 0.00 | 4.05 | 20.70 | |||
MIST | 1.90 | 0.19 | 0.12 | 0.24 | 1.61 | 7.19 | 18.66 | |||
MCRB | 4.93 | 0.19 | 0.02 | 0.60 | 5.66 | 10.84 | 28.84 | |||
LUMO | 2.44 | 0.38 | 0.06 | (0.43) | 2.72 | 5.95 | 16.25 |
Replimune Corporate Management
Sushil Patel | Chief Officer | Profile | |
Colin Love | Chief Officer | Profile | |
Christopher Sarchi | Chief Officer | Profile | |
Tanya MS | Chief Officer | Profile | |
Pamela Esposito | Chief Business Officer | Profile |